针对目前的问题，弥补缺陷、恢复消费者信心是当务之急。企业必须从思想根源上转变认识，牢牢守住 自身核心价值，抵制一切可能对品牌形象产生负面影响的短视行为。如果要做到这一点，恐怕必须反思 目前的商业模式，甚至作一定的取舍。而如果退而求其次，延续现有这种商业模式，那就必须在相关流 程管理上下功夫。需要明确划定授权范畴、产品质量准则以及宣传规范，并在法律文书中清晰设定违约 后果，构建覆盖全过程的质量管理体系。这要求企业对内必须形成一套严格的授权管理制度，厘清商标 使用的权限范围。 在产品质量控制层面，必须设立一套能够覆盖产品从生产到退出市场全过程监督的制度。例如，建立可 动态更新的供应商评估机制，随时对生产方开展不预先通知的突击检查，并借助防伪与溯源技术，实现 从生产到销售环节的全程追踪，以确保生产过程规范、受控。 此外，品牌方还应强化事后监督与权利维护，主动开展市场监测，借助网络平台巡查与用户回馈等渠 道，及时察觉未经许可的"打擦边球"行为或假冒伪劣商品。一旦发现质量问题或侵权现象，须立即启动 应对程序，包括依据协议追究违约责任、向市场监管部门报告或通过法律诉讼维权，使违规者承受应有 代价。 不论商业形态如何演变， ...

Core Viewpoint - The article discusses the investigation into a product labeled as "Beijing Tongrentang 99% High Purity Antarctic Krill Oil," which has been found to contain no phospholipids despite claiming a content of 43% [4]. Group 1: Investigation and Response - The Chengdu New District Market Supervision Administration has established a joint investigation team to look into Beijing Tongrentang (Sichuan) Health Pharmaceutical Co., Ltd. following media reports about the product [1]. - The company has been officially filed for investigation, and the case is currently under review, with a commitment to protect consumer rights [1]. - Beijing Tongrentang issued a statement of apology and has dispatched a special task force to Sichuan for a comprehensive investigation of the involved product [5]. Group 2: Product Claims and Findings - The product in question, marketed as "Beijing Tongrentang 99% High Purity Antarctic Krill Oil," was highlighted by the Shanghai Consumer Protection Committee for its misleading claims, as the actual phospholipid content was found to be zero [4]. - The distributor of the product is Beijing Tongrentang (Sichuan) Health Pharmaceutical Co., Ltd., while the manufacturer is Anhui Habao Pharmaceutical Co., Ltd. [4].

Core Viewpoint - The incident involving Antarctic krill oil has highlighted management issues within Beijing Tongrentang (Group), leading to a brand trust crisis despite the company's long history of 356 years [2][3]. Group 1: Incident Overview - On December 20, Beijing Tongrentang officially apologized to consumers and announced a zero-tolerance brand management initiative, along with a comprehensive review of brand usage across its subsidiaries [1]. - The Antarctic krill oil product claimed to contain "99% high-purity Antarctic krill oil" with "43% phospholipid content" and was said to be made from imported Chilean raw materials, but testing revealed zero phospholipid content [2]. Group 2: Management and Trust Issues - The company operates a vast network with seven subsidiaries, over 2,400 retail terminals, and 36 production bases, producing more than 2,600 types of pharmaceuticals and health products, which complicates management and quality control [2][3]. - Previous incidents, such as the "honey scandal" in 2018, indicate recurring quality control issues and management failures, suggesting a systemic problem within the company's operational framework [3]. Group 3: Recommendations for Improvement - To restore brand trust, the company must implement detailed quality control standards for its extensive product range and establish unified brand authorization protocols across its production bases [4]. - A commitment to zero tolerance for management failures must be integrated into every management process, rather than merely stated in public declarations, to prevent further erosion of consumer trust [5].

Core Viewpoint - The incident involving "Tongrentang Antarctic Krill Oil" has raised significant concerns due to the product's reported phospholipid content being zero, leading to investigations and legal actions against the involved companies [1][3][4]. Group 1: Investigation and Legal Actions - The Chengdu Xindu District Market Supervision Administration has established a joint investigation team to look into Beijing Tongrentang (Sichuan) Health Pharmaceutical Co., Ltd. and has initiated legal proceedings against the company [1][3]. - Beijing Tongrentang Health Pharmaceutical Co., Ltd. has ordered the cessation of sales of the implicated product and is conducting a full process review and traceability of the product [4]. - The Shanghai Consumer Protection Commission has raised questions regarding the accountability and beneficiaries of the alleged counterfeit and fraudulent activities related to the product [4]. Group 2: Company Responses and Consumer Protection - Beijing Tongrentang Group has issued an apology and stated that it will pursue legal responsibility for trademark infringement against Sichuan Health, Habbo Pharmaceutical, and related e-commerce platforms [4][5]. - The Shanghai Consumer Protection Commission has welcomed the proactive stance of Beijing Tongrentang Group and emphasized the importance of maintaining the brand's reputation, which has been built over 356 years [5].

Core Viewpoint - The investigation into the "Antarctic Krill Oil Gel Candy" by Beijing Tongrentang (Sichuan) Health Pharmaceutical Co., Ltd. has revealed serious allegations of product misrepresentation and fraud, leading to regulatory scrutiny and potential legal consequences for the involved parties [1][6][7]. Group 1: Investigation and Regulatory Actions - The Chengdu New District Market Supervision Administration has established a joint investigation team to look into the allegations against Beijing Tongrentang (Sichuan) Health Pharmaceutical Co., Ltd. and has initiated a case against the company [1]. - The Shanghai Consumer Protection Committee has conducted tests on 15 popular Antarctic krill oil products, finding that one product from Beijing Tongrentang contained no actual krill oil, despite claims of high purity [3]. - The Shanghai Consumer Protection Committee has urged the involved companies to conduct self-examinations, apologize to consumers, recall the problematic products, and provide legal compensation [6]. Group 2: Company Responses and Accountability - Beijing Tongrentang Group has issued a public apology, expressing deep concern over the consumer rights violations and committing to a thorough investigation of the involved products [6][7]. - The company has mandated the immediate removal of the implicated products from the market and is pursuing legal action against the responsible parties for trademark infringement and misleading marketing practices [7]. - A special task force will be dispatched by Beijing Tongrentang to conduct a comprehensive review of the situation and hold accountable those responsible for the mismanagement and oversight failures [7].

Core Viewpoint - The Chengdu New District Market Supervision Administration has initiated an investigation into the "Antarctic Krill Oil" incident involving Beijing Tongrentang (Sichuan) Health Pharmaceutical Co., Ltd, following media reports on related consumer rights violations [1] Group 1: Investigation and Regulatory Actions - A joint investigation team from provincial, municipal, and district market supervision departments has been established to investigate the involved company [1] - The company has been officially filed for investigation, and the case is currently under review [1] Group 2: Company Response and Consumer Protection - Beijing Tongrentang Group has issued an apology regarding the consumer rights damage caused by the "Antarctic Krill Oil" incident and announced a special action for strict brand management [1] - The company has dispatched a special working group to Sichuan to verify the involved products and has ordered the relevant distributors to remove the products from shelves and compensate consumers legally [1] - The company plans to pursue legal responsibility for trademark infringement against Sichuan Health, Habao Pharmaceutical, and related e-commerce platforms [1] - To further protect consumer rights, the company will conduct a comprehensive inspection of brand usage, clean up "borderline" brand names and improper trademark usage, and standardize e-commerce platform authorized store logos to guide consumers in identifying legitimate channels [1]

Core Viewpoint - The Chengdu New District Market Supervision Administration has initiated an investigation into Beijing Tongrentang (Sichuan) Health Pharmaceutical Co., Ltd. regarding the "Antarctic Krill Oil Gel Candy" following media reports of discrepancies in product content [1] Group 1: Investigation and Regulatory Actions - A joint investigation team has been established by provincial, municipal, and district market regulatory departments to examine the situation at Beijing Tongrentang (Sichuan) Health Pharmaceutical Co., Ltd. [1] - The company has been officially filed for investigation, and the case is currently under review [1] - Future actions will be taken based on the investigation results to ensure strict legal compliance and protect consumer rights [1] Group 2: Product Testing and Findings - Recent testing by the Shanghai Consumer Protection Committee revealed that a product labeled as "Beijing Tongrentang 99% High Purity Antarctic Krill Oil" contained an actual krill oil content of "0%" [1] - The manufacturer of the product is Anhui Hab Pharmaceutical Co., Ltd., while the distributor is Beijing Tongrentang (Sichuan) Health Pharmaceutical Co., Ltd. [1]

Core Viewpoint - The incident involving Antarctic krill oil has exposed management issues within Beijing Tongrentang (Group), leading to a brand trust crisis despite the company's long history of 356 years [1][3]. Group 1: Incident Overview - On December 20, Tongrentang issued a formal apology and announced a zero-tolerance brand management initiative following the Antarctic krill oil incident [1]. - The product in question claimed to contain "99% high-purity Antarctic krill oil" with a "phospholipid content of 43%" but was found to have zero phospholipid content in testing [2]. - This incident is not isolated; a previous scandal in 2018, known as the "honey incident," involved the use of expired honey by a subsidiary, further damaging the brand's reputation [2]. Group 2: Management and Quality Control Issues - The complexity of Tongrentang's operations, with over 2,600 products across various categories and 36 production bases, has made quality control and brand management increasingly challenging [2][4]. - The company's large scale, which should provide a competitive advantage, has instead become a liability, leading to a loss of consumer trust [2]. - Effective management of brand assets requires comprehensive monitoring of all subsidiaries and associated companies throughout the production process [2][4]. Group 3: Consumer Trust and Brand Reputation - Consumer sentiment has shifted dramatically, with some expressing a complete loss of trust in the brand due to repeated management failures [3]. - The erosion of trust stems from a series of management lapses, indicating that consumers value the quality promise behind the Tongrentang brand rather than just the name itself [2][3]. - To restore trust, the company must implement rigorous quality control standards and a unified brand authorization protocol across all operations [4][5].

Group 1 - The Chengdu market supervision department has established a joint investigation team to look into the "Antarctic krill oil gummy candy" incident involving Beijing Tongrentang (Sichuan) Health Pharmaceutical Co., Ltd [1][3] - The investigation is a response to recent media reports, and the company has been officially filed for investigation [1][3] - The authorities emphasize their commitment to protecting consumer rights and will take serious legal actions based on the investigation results [1][3]

文章提到，上海市消保委依法对南极磷虾油产品问题开展社会监督和消费提醒，既是履行保护消费者合 法权益的本职，也是旨在净化健康功能性食品市场和维护中华老字号信誉。北京同仁堂品牌已有356年 历史，其在广大消费者心目中的地位是由历代经营者和无数工匠的心血累积起来的，需要格外珍惜。所 以，上海市消保委期望北京同仁堂集团能以此次事件为契机，推进实施品牌长效维护和增信机制，共同 维护健康有序的消费环境，让"北京同仁堂"这块金字招牌越来越亮。 日前，上海市消保委揭露"同仁堂南极磷虾油"产品磷脂含量为0，把品牌方推至舆论的风口浪尖。12月 20日，中国北京同仁堂（集团）有限责任公司发布声明致歉，称将依法追究四川健康、哈博药业及相关 电商平台的商标侵权等责任。南都N视频记者注意到，同日，上海市消保委再次发文称，欢迎北京同仁 堂集团正视问题的态度，希望该集团能将各项整改举措落实到位。 涉事产品。 上海市消保委20日发文称，欢迎北京同仁堂集团正视问题的态度。该集团在声明中致歉广大消费者和社 会各界，并表示要依法依规对消费者进行赔偿，要开展"零容忍"品牌严管专项行动等等，体现了对消费 者权益的重视和整改的决心，值得肯定。 文章指出， ...